BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

582 related articles for article (PubMed ID: 32633395)

  • 1. METTL14 regulates M6A methylation-modified primary miR-19a to promote cardiovascular endothelial cell proliferation and invasion.
    Zhang BY; Han L; Tang YF; Zhang GX; Fan XL; Zhang JJ; Xue Q; Xu ZY
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):7015-7023. PubMed ID: 32633395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. METTL14 mediates m
    Dong X; Liao B; Zhao J; Li X; Yan K; Ren K; Zhang X; Bao X; Guo W
    Mol Med Rep; 2023 Sep; 28(3):. PubMed ID: 37449516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of METTL14-mediated m
    Gong S; Wang S; Shao M
    J Mol Med (Berl); 2022 Dec; 100(12):1771-1785. PubMed ID: 36352154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. METTL3-mediated m6A modification promotes processing and maturation of
    Gong Y; Jiang Q; Liu L; Liao Q; Yu J; Xiang Z; Luo X
    Physiol Genomics; 2022 Sep; 54(9):337-349. PubMed ID: 35759451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. METTL14-mediated N6-methyladenosine modification induces the ferroptosis of hypoxia/reoxygenation-induced cardiomyocytes.
    Zhao C; Li J
    J Cardiothorac Surg; 2024 Apr; 19(1):265. PubMed ID: 38664788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.
    Chen X; Xu M; Xu X; Zeng K; Liu X; Pan B; Li C; Sun L; Qin J; Xu T; He B; Pan Y; Sun H; Wang S
    Mol Cancer; 2020 Jun; 19(1):106. PubMed ID: 32552762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. METTL14 promotes the migration and invasion of breast cancer cells by modulating N6‑methyladenosine and hsa‑miR‑146a‑5p expression.
    Yi D; Wang R; Shi X; Xu L; Yilihamu Y; Sang J
    Oncol Rep; 2020 May; 43(5):1375-1386. PubMed ID: 32323801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP.
    Ma Z; Li Q; Liu P; Dong W; Zuo Y
    Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. piRNA-14633 promotes cervical cancer cell malignancy in a METTL14-dependent m6A RNA methylation manner.
    Xie Q; Li Z; Luo X; Wang D; Zhou Y; Zhao J; Gao S; Yang Y; Fu W; Kong L; Sun T
    J Transl Med; 2022 Jan; 20(1):51. PubMed ID: 35093098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N6-methyladenosine (m6A)-mediated up-regulation of long noncoding RNA LINC01320 promotes the proliferation, migration, and invasion of gastric cancer via miR495-5p/RAB19 axis.
    Hu N; Ji H
    Bioengineered; 2021 Dec; 12(1):4081-4091. PubMed ID: 34288797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-1306-5p Regulates the METTL14-Guided m6A Methylation to Repress Acute Myeloid Leukemia.
    Li J; Wu Y; Wang M; Chen X; Li Z; Bai X; Wu H
    Comput Math Methods Med; 2022; 2022():5787808. PubMed ID: 36118827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methyltransferase-like 3 facilitates lung cancer progression by accelerating m6A methylation-mediated primary miR-663 processing and impeding SOCS6 expression.
    Li S; Lu X; Zheng D; Chen W; Li Y; Li F
    J Cancer Res Clin Oncol; 2022 Dec; 148(12):3485-3499. PubMed ID: 35907010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N(6)-adenosine-methyltransferase-14 promotes glioma tumorigenesis by repressing argininosuccinate synthase 1 expression in an m6A-dependent manner.
    Miao YQ; Chen W; Zhou J; Shen Q; Sun Y; Li T; Wang SC
    Bioengineered; 2022 Jan; 13(1):1858-1871. PubMed ID: 35012429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mettl14-mediated m6A modification modulates neuron apoptosis during the repair of spinal cord injury by regulating the transformation from pri-mir-375 to miR-375.
    Wang H; Yuan J; Dang X; Shi Z; Ban W; Ma D
    Cell Biosci; 2021 Mar; 11(1):52. PubMed ID: 33706799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner.
    Han J; Wang JZ; Yang X; Yu H; Zhou R; Lu HC; Yuan WB; Lu JC; Zhou ZJ; Lu Q; Wei JF; Yang H
    Mol Cancer; 2019 Jun; 18(1):110. PubMed ID: 31228940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. METTL14 aggravates endothelial inflammation and atherosclerosis by increasing FOXO1 N6-methyladeosine modifications.
    Jian D; Wang Y; Jian L; Tang H; Rao L; Chen K; Jia Z; Zhang W; Liu Y; Chen X; Shen X; Gao C; Wang S; Li M
    Theranostics; 2020; 10(20):8939-8956. PubMed ID: 32802173
    [No Abstract]   [Full Text] [Related]  

  • 17. METTL14-mediated N
    Liu Z; Sun T; Piao C; Zhang Z; Kong C
    Cell Commun Signal; 2022 Mar; 20(1):36. PubMed ID: 35305660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. METTL14 suppresses pyroptosis and diabetic cardiomyopathy by downregulating TINCR lncRNA.
    Meng L; Lin H; Huang X; Weng J; Peng F; Wu S
    Cell Death Dis; 2022 Jan; 13(1):38. PubMed ID: 35013106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-4729 regulates TIE1 mRNA m6A modification and angiogenesis in hemorrhoids by targeting METTL14.
    Liu T; Zhou H; Lu H; Luo C; Wang Q; Peng Y; Yang W; Xin Y
    Ann Transl Med; 2021 Feb; 9(3):232. PubMed ID: 33708859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. METTL14-Mediated miR-30c-1-3p Maturation Represses the Progression of Lung Cancer via Regulation of MARCKSL1 Expression.
    Li F; Zhao J; Wang L; Chi Y; Huang X; Liu W
    Mol Biotechnol; 2022 Feb; 64(2):199-212. PubMed ID: 34586620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.